Discontinuation report ETODOLAC
Report ID | 70191 |
Drug Identification Number | 02232318 |
Brand name | ETODOLAC |
Common or Proper name | ETODOLAC |
Company Name | AA PHARMA INC |
Market Status | DORMANT |
Active Ingredient(s) | ETODOLAC |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100BTL |
ATC code | M01AB |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2018-11-12 |
Remaining supply date | 2018-11-12 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Expiry 2019-05-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2019-01-14 | French | Compare |
v3 | 2019-01-14 | English | Compare |
v2 | 2018-12-20 | French | Compare |
v1 | 2018-12-20 | English | Compare |
Showing 1 to 4 of 4